奧利司他
Orlistat;N-FORMYL-L-LEUCINE (1S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL]METHYL]DODECYL ESTER;RO-18-0647;(S)-2-FORMYLAMINO-4-METHYL-PENTANOIC ACID (S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL]METHYL]-DODECYL ESTER;(-)-TETRAHYDROLIPSTATIN;XENICAL;(-)-Tetrahydrolipstatin(EquivalentToOrlistat);Orlipastat;Xenical, (-)-Tetrahydrolipstatin, N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl Ester,;Orlistat, Tetrahydolipstat;ORLIPASTATUM;(-)-Tetrahydrolipstatin, Ro-18-0647, N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester;L-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester;N-Formyl-L-leucine (1S)-1-[[(2S)-3α-hexyl-4-oxooxetan-2β-yl]methyl]dodecyl ester;N-Formyl-L-leucine (S)-1-[[(2S)-3α-hexyl-4-oxooxetane-2β-yl]methyl]dodecyl ester;Orlistat Powder;(S)-2-FORMYLAMINO-4-METHYL-PENTANOIC ACID;[(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate;002;Alli;Ro 18-0647;Tetrahydrolipstatin;THLP;(?)-Tetrahydrolipstatin;Orlipastatum [INN-Latin];C29H53NO5;(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl (2S)-2-formamido-4-methylpentanoate;Orlistat (Alli, Xenical);MLS002207022;N-Formyl-L-le;L-Leucine, N-formyl-, 1-[(3-hexyl-4-oxo-2-oxetanyl)methyl]dodecyl ester, [2S-[2α(R*),3β]]- (ZCI);L;Listata;Ro 18-0647/002;96829-58-2;MLS001423955;ORLISTAT [MART.];NCGC00165856-14;SW197481-2;NSC 758881;NCGC00165856-15;AHLBNYSZXLDEJQ-FWEHEUNISA-N;HSDB 7556;Orlistat (Standard);Tox21_111437_1;R-212;ORLISTAT [JAN];N-formyl-L-leucine (1S)-1-{[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl}dodecyl ester;SR-01000759417;HMS3413P06;BRD-K63343048-001-12-2;Ro18-0647;DB01083;N-formyl-L-leucine-(S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]-dodecyl ester;Ro-18-0647/002;UNII-95M8R751W8;HMS3677P06;N-Formyl-L-leucine, ester with (3S,4S)-3-hexyl-4-((2S)-2-hydroxytridecyl)-2-oxetanone;ORLISTAT [INN];s1629;Q424163;Q-201519;HMS2051I08;(-)-tetrahydrolipostatin;N-formyl-L-leucine (S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester;95M8R751W8;tetrahydrolipastatin;AB00639987-09;CHEBI:94686;ORLISTAT [USP-RS];ORLISTAT [ORANGE BOOK];CCG-100851;SMR000466339;NC00101;(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl N-formyl-L-leucinate;MFCD05662360;HY-B0218R;NCGC00165856-01;DTXCID40820067;O0381;CAS-96829-58-2;ORLISTAT [VANDF];CS-0694775;L-Leucine, N-formyl-, 1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester, (2S-(2alpha(R*),3beta))-;EN300-268136;Orlistat, >=98%, solid;BDBM24567;104872-04-0;Ro-180647002;BIDD:GT0853;NCGC00095128-01;Tetrahydrolipstatin;Ro-18-0647;BCP0726000044;DTXSID8023395;NCGC00165856-03;Ro-180647-002;Orlistat [USAN:INN:BAN];L-Leucine, N-formyl-, (1S)-1-(((2S,3S)-3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester;Xenical (TN);ORLISTAT [WHO-DD];(-)-Tetrahydrolipstatin; Orlistat; Ro 18-0647/002; Tetrahydrolipstatin; Xenical; L-Leucine, N-formyl-,...